Medico Remedies Ltd

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations2015 we hereby inform you that the Board of Directors of our Company at their meeting held todayi.e. 11th May 2023 has inter alia considered and approved the following:1. Audited Standalone Financial Results of the Company for the quarter ended 31st March 2023and Audited Financial Statement for the year ended on 31st March 2023 along with theAuditors Report thereon.2. The Boards Report and its annexures Management Discussion Analysis (MDA) and CorporateGovernance Report of the Company for the financial year ended on 31st March 2023.